P. Gallo

D. D’Avola, P. Gallo, G. Dicuonzo, 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Effects of disease modifying therapies on brain and grey matter atrophy in relapsing remitting multiple sclerosis

P. Gallo, M. Margoni, A. Favaretto, 2018, Multiple Sclerosis and Demyelinating Disorders.

Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis

M. Filippi, M. Duddy, M. Trojano, 2021, Journal of Neurology.

Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis

P. Gallo, Marta Pengo, F. Rinaldi, 2022, Journal of Neurology.

Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers

M. Inglese, L. Roccatagliata, F. Nobili, 2019, EJNMMI Radiopharmacy and Chemistry.

Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.

P. Gallo, E. Riva, U. Vespasiani-Gentilucci, 2015, World journal of gastroenterology.

Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management

M. Silletta, R. Antonelli Incalzi, P. Gallo, 2021, Chemotherapy.

A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN

M. Filippi, G. Comi, M. Trojano, 2004, Journal of the Neurological Sciences.

Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study

M. Rovaris, M. Filippi, M. Calabrese, 2009, Multiple sclerosis.

Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions.

P. Gallo, U. Vespasiani-Gentilucci, G. Galati, 2019, Medical ultrasonography.

Breath‐print analysis by e‐nose may refine risk stratification for adverse outcomes in cirrhotic patients

M. Santonico, G. Pennazza, R. Antonelli Incalzi, 2017, Liver international : official journal of the International Association for the Study of the Liver.

The safety profile of cyclophosphamide in multiple sclerosis therapy

M. Calabrese, P. Gallo, P. Perini, 2007, Expert opinion on drug safety.

Letter to the Editor

P. Tonin, F. Piccione, P. Gallo, 2002 .

Tumour necrosis factor-alpha in infectious meningitis.

K. Frei, A. Fontana, D. Nadal, 1989, Archives of disease in childhood.

Cytokine regulation of astrocyte function: in-vitro studies using cells from the human brain

A. Carè, C. Peschle, G. Levi, 1995, International Journal of Developmental Neuroscience.

The cerebrospinal fluid transferrin/Tau proteins A study by two-dimensional polyacrylamide gel electrophoresis (2D) and agarose isoelectrofocusing (IEF) followed by double-antibody peroxidase labeling and avidin-biotin amplification

B. Tavolato, L. Battistin, F. Bracco, 1985, Journal of the Neurological Sciences.

Alemtuzumab for multiple sclerosis: the new concept of immunomodulation

D. Centonze, P. Gallo, M. Marrosu, 2017, Multiple Sclerosis and Demyelinating Disorders.

Appropriate therapies predict long-term mortality in primary and secondary prevention of sudden cardiac death

P. Gallo, A. De Simone, C. Ciardiello, 2013, Journal of cardiovascular medicine.

Evaluation of myocardial functional parameters during intravenous cyclophosphamide pulse therapy: a case report.

P. Tonin, F. Piccione, P. Gallo, 2002, Multiple sclerosis.

Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience

B. Vincenzi, G. Tonini, P. Gallo, 2015, Expert review of anticancer therapy.

The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention

P. Gallo, U. Vespasiani-Gentilucci, A. Picardi, 2016, Archives of medical science : AMS.

Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.

G. Mascioli, A. Curnis, P. Gallo, 2005, Italian heart journal : official journal of the Italian Federation of Cardiology.

Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age.

E. Schena, P. Gallo, U. Vespasiani-Gentilucci, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Natalizumab in the pediatric MS population: results of the Italian registry

M. Filippi, C. Pozzilli, L. Grimaldi, 2015, BMC Neurology.

Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies

C. Briani, M. Cacciavillani, P. Gallo, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

Adding Pre-procedural Glycemia to the Mehran Score Enhances Its Ability to Predict Contrast-induced Acute Kidney Injury in Patients With and Without Diabetes Undergoing Percutaneous Coronary Intervention

G. Polizzi, A. Sticchi, P. Gallo, 2020 .

The MBP-reactive repertoire is shaped by recognition of minor histocompatibility antigens

P. Gallo, F. Ronchese, P. Perini, 2004, Journal of Neuroimmunology.

A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-γ in multiple sclerosis CSF and serum

B. Tavolato, P. Gallo, Å. Sidén, 1991, Journal of the Neurological Sciences.

A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis CSF and serum.

B. Tavolato, P. Gallo, Å. Sidén, 1991, Journal of the neurological sciences.

Hyperreflective Foci in the Retina of Active Relapse-Onset Multiple Sclerosis.

P. Gallo, E. Pilotto, E. Midena, 2020, Ophthalmology.

Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion

D. Centonze, M. Filippi, C. Pozzilli, 2022, Journal of Neurology.

Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS

C. Pozzilli, G. Comi, L. Grimaldi, 2019, Neurology: Neuroimmunology & Neuroinflammation.

Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

P. Gallo, U. Vespasiani-Gentilucci, G. Galati, 2014, World journal of gastroenterology.

Cerebrospinal fluid analysis in HIV‐1‐infected children: immunological and virological findings before and after AZT therapy

B. Tavolato, L. Chieco‐Bianchi, P. Gallo, 1994, Acta paediatrica.

Immunological Markers in the Cerebrospinal Fluid of HIV‐1‐Infected Children

B. Tavolato, L. Chieco‐Bianchi, P. Gallo, 1991, Acta paediatrica Scandinavica.

Free light chains of immunoglobulins in the cerebrospinal fluid of human immunodeficiency virus type 1-infected patients

B. Tavolato, L. Chieco‐Bianchi, A. Amadori, 1990, Journal of Neuroimmunology.

Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion

D. Centonze, M. Filippi, C. Pozzilli, 2022, Journal of Neurology.

Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study

D. Centonze, G. Marfia, M. Filippi, 2022, Neurological Sciences.

Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge.

G. Perrone, P. Gallo, A. Afeltra, 2011, World journal of gastroenterology.

IgG oligoclonal bands in sera of HIV-1 infected patients are mainly directed against HIV-1 determinants.

L. Chieco‐Bianchi, A. Amadori, P. Gallo, 1990, AIDS research and human retroviruses.

Intrathecal Synthesis of Anti‐HIV Oligoclonal IgG in HIV‐Seropositive Patients Having No Signs of HIV‐Induced Neurologic Diseases

B. Tavolato, L. Chieco‐Bianchi, P. Gallo, 1988, Annals of the New York Academy of Sciences.

Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty.

P. Gallo, M. Miglionico, P. Pozzilli, 2018, The American journal of cardiology.

Tumor necrosis factor alpha (TNF alpha) and neurological diseases. Failure in detecting TNF alpha in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours.

B. Tavolato, P. Gallo, M. Piccinno, 1989, Journal of neuroimmunology.

Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy

P. Gallo, F. Rinaldi, P. Perini, 2017, Neurology: Neuroimmunology & Neuroinflammation.

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

C. Pozzilli, V. Martinelli, G. Comi, 2011, Neurology.

Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations.

R. Grasso, P. Gallo, A. Afeltra, 2011, The American journal of the medical sciences.

Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients

R. Zinkernagel, K. Frei, A. Meager, 1988, The Journal of experimental medicine.

Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis

P. Gallo, Marta Pengo, F. Rinaldi, 2022, Journal of Neurology.

Transferrin Receptors in the Central Nervous System

B. Giometto, B. Tavolato, P. Gallo, 1993 .

Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis

M. Calabrese, L. Battistin, P. Gallo, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Response letter regarding the article “Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study,” by Calabrese, et al.

M. Filippi, M. Calabrese, P. Gallo, 2009 .

Alemtuzumab‐induced autoimmune thyroid events in patients with relapsing‐remitting multiple sclerosis: A real‐life and monocentric experience at a tertiary‐level centre

C. Mian, M. Plebani, C. Cosma, 2021, Clinical endocrinology.

Experimental allergic encephalomyelitis in the monkey: humoral immunity and blood-brain barrier function

B. Tavolato, L. Battistin, F. Bracco, 1989, The Italian Journal of Neurological Sciences.

Experimental allergic encephalomyelitis in the monkey: humoral immunity and blood-brain barrier function

B. Tavolato, L. Battistin, F. Bracco, 2006, The Italian Journal of Neurological Sciences.

Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing—remitting multiple sclerosis

M. Calabrese, P. Gallo, F. Rinaldi, 2010, Multiple sclerosis.

The HLA-DR13 haplotype is associated with “benign” multiple sclerosis in northeast Italy

P. Gallo, P. Perini, G. Biasi, 2001, Neurology.

The Costimulatory Molecule B7 is Expressed on Human Microglia in Culture and in Multiple Sclerosis Acute Lesions

R. Simone, C. Peschle, G. Levi, 1995, Journal of neuropathology and experimental neurology.

Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study

D. Centonze, G. Marfia, M. Filippi, 2022, Neurological Sciences.

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study

G. Comi, E. Scarpini, A. Ghezzi, 2019, Multiple sclerosis.

Neurite orientation dispersion and density imaging discloses early changes in the normal-appearing white matter in paediatric multiple sclerosis

A. Bertoldo, L. Finos, F. Causin, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

Severe relapses under fingolimod treatment prescribed after natalizumab

D. Centonze, S. Rossi, P. Gallo, 2012, Neurology.

Multiple Sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls

P. Gallo, S. Sivieri, A. Ferrarini, 1998, Multiple sclerosis.

Switching therapy from natalizumab to fingolimod in relapsing–remitting multiple sclerosis: clinical and magnetic resonance imaging findings

M. Calabrese, P. Gallo, F. Rinaldi, 2012, Multiple sclerosis.

Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha.

A. Carè, C. Peschle, G. Levi, 1992, Journal of Immunology.

Interleukin-1 receptor antagonist, soluble tumor necrosis factor-a receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-b1a.

P. Gallo, P. Perini, A. Facchinetti, 2000 .

Cytokines in multiple sclerosis cerebrospinal fluid and serum

B. Tavolato, P. Gallo, 1996 .

Intrathecal cytokine synthesis in inflammatory and demyelinating diseases of the central nervous system.

B. Tavolato, P. Gallo, 1994 .

Cyclophosphamide Pulses Therapy after Natalizumab Discontinuation for Multiple Sclerosis: A Multicentre Study

L. Provinciali, M. Calabrese, G. Mancardi, 2015 .

M-CSF production by HIV-1-infected monocytes and its intrathecal synthesis implications for neurological HIV-1-related disease

B. Tavolato, L. Chieco‐Bianchi, P. Gallo, 1994, Journal of Neuroimmunology.

Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology

S. Morini, P. Gallo, C. Pedone, 2016, PloS one.

Hepatitis A virus in a medical setting in Madagascar: a lesson for public health.

M. Ciccozzi, A. Ciccaglione, M. Giovanetti, 2015, The new microbiologica.

Overview of the management of relapsing−remitting multiple sclerosis and practical recommendations

P. Gallo, B. van Wijmeersch, 2015, European journal of neurology.

Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS.

P. Gallo, C. Baracchini, 2011, Neurology.

Cyclophosphamide-based combination therapies for autoimmunity

M. Calabrese, P. Gallo, P. Perini, 2008, Neurological Sciences.

Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks

M. Calabrese, P. Gallo, P. Perini, 2009, Neurological Sciences.

Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD

G. Cantalupo, Massimiliano Valeriani, N. Nardocci, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP

B. Tavolato, F. Lolli, F. Pinto, 1997, Journal of the Neurological Sciences.

Automatic Segmentation of Gray Matter Multiple Sclerosis Lesions on DIR Images

Alessandra Bertoldo, Enrico Grisan, Massimiliano Calabrese, 2014 .

Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis.

M. Filippi, M. Rocca, A. Giorgio, 2021, JAMA neurology.

Aging with multiple sclerosis: prevalence and profile of cognitive impairment

A. Ghezzi, F. Mattioli, F. Patti, 2019, Neurological Sciences.

Automatic segmentation of gray matter multiple sclerosis lesions on FLAIR and DIR images

E. Grisan, A. Bertoldo, E. Veronese, 2010 .

Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

G. Bernardi, M. Trojano, L. Grimaldi, 1994, Journal of neurology, neurosurgery, and psychiatry.

Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis

M. Sormani, P. Gallo, A. Signori, 2017, PloS one.

Multiple sclerosis and autoimmune diseases

M. Calabrese, L. Battistin, P. Gallo, 2006, Journal of Neurology.

Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures

P. Gallo, U. Vespasiani-Gentilucci, A. Picardi, 2022, World journal of gastroenterology.

Effect of parenteral administration of GM1 on cytokines and anti-ganglioside antibody patterns. Preliminary report in normal human individuals

B. Tavolato, L. Callegaro, P. Gallo, 1992, Journal of Neuroimmunology.

A challenging alfa-fetoprotein in a cirrhotic patient.

P. Gallo, C. Taffon, A. O. Muda, 2014, Acta gastro-enterologica Belgica.

Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination

P. Gallo, U. Vespasiani-Gentilucci, G. Galati, 2014, BMC Gastroenterology.

Immunogenicity of interferon beta: differences among products

Paolo Gallo, P. Gallo, A. Bertolotto, 2004, Journal of Neurology.

Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study

Giorgio Pennazza, Marco Santonico, Claudio Pedone, 2016, Scientific Reports.

Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship

P. Gallo, G. Minotti, P. Menna, 2014, Journal of viral hepatitis.

Renal impairment and anemia during triple therapy.

P. Gallo, U. Vespasiani-Gentilucci, A. Picardi, 2014, Journal of hepatology.

The heritage of glatiramer acetate and its use in multiple sclerosis

D. Centonze, C. Pozzilli, G. Tedeschi, 2016, Multiple Sclerosis and Demyelinating Disorders.

No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset

M. Calabrese, F. Causin, P. Gallo, 2011, Annals of neurology.

Production of B Cell Stimulatory Factor-2 and Interferon Y in the Central Nervous System during Viral Meningitis and Encephalitis Evaluation in a Murine Model Infection and in Patients Brief Definitive Report

R. Zinkernagel, K. Frei, A. Fontana, 1988 .

Heterogeneity of Cortical Lesions in Multiple Sclerosis: An MRI Perfusion Study

Alessandra Bertoldo, Massimiliano Calabrese, Marco Castellaro, 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Multiple sclerosis and autoimmune diseases

M. Calabrese, L. Battistin, P. Gallo, 2006, Journal of Neurology.

PM2.5 levels strongly associate with multiple sclerosis prevalence in the Province of Padua, Veneto Region, North-East Italy

M. Ermani, P. Gallo, F. Tateo, 2018, Multiple sclerosis.

Cortical Pathology in RRMS: Taking a Cue from Four Sisters

M. Calabrese, P. Gallo, F. Rinaldi, 2012, Multiple sclerosis international.

Gray Matter Pathology in MS: A 3-Year Longitudinal Study in a Pediatric Population

M. Calabrese, C. Romualdi, P. Gallo, 2012, American Journal of Neuroradiology.

Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis

Chiara Romualdi, Massimiliano Calabrese, Francesca Rinaldi, 2009, Journal of Neurology, Neurosurgery & Psychiatry.

Effect of high‐dose steroid therapy on T‐cell subpopulations A longitudinal study in MS patients

B. Tavolato, P. Gallo, P. Rizzotti, 1994, Acta neurologica Scandinavica.

Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry

C. Mussi, L. Fenoglio, M. Barbagallo, 2020, Internal and Emergency Medicine.

No MRI evidence of cortical lesions in neuromyelitis optica

M. Calabrese, P. Gallo, Byung‐Chul Lee, 2012, Neurology.

CCSVI and MS: no meaning, no fact

P. Gallo, M. Atzori, C. Baracchini, 2013, Neurological Sciences.

Fact or fiction: Chronic cerebro-spinal insufficiency

P. Gallo, C. Baracchini, 2012 .

Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo.

P. Gallo, A. Bertolotto, P. Perini, 2001, European cytokine network.

Time-course of interleukin-2 receptor expression in interferon beta-treated multiple sclerosis patients

B. Tavolato, P. Gallo, M. Buttarello, 1998, Journal of Neuroimmunology.

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

Ludwig Kappos, Xavier Montalban, Frederik Barkhof, 2010, The New England journal of medicine.

Current treatment options for HCC: from pharmacokinetics to efficacy and adverse events in liver cirrhosis.

S. di Donato, M. Silletta, P. Gallo, 2020, Current drug metabolism.

Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system

B. Tavolato, F. Lolli, P. Gallo, 1994, Journal of the Neurological Sciences.

Immunotherapies for Multiple Sclerosis

P. Gallo, P. Perini, 1999 .

Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and γ-IFN levels in serum and cerebrospinal fluid

B. Giometto, B. Tavolato, P. Gallo, 1989, Journal of the Neurological Sciences.

Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables

P. Gallo, R. Antonelli-Incalzi, U. Vespasiani-Gentilucci, 2018, World journal of gastroenterology.

Interleukin‐2 levels in serum and cerebrospinal fluid of multiple sclerosis patients

B. Tavolato, P. Gallo, M. Piccinno, 1988, Annals of neurology.

The clinical impact of interferon beta antibodies in relapsing-remitting MS

M. Calabrese, P. Gallo, P. Perini, 2004, Journal of Neurology.

Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-β1b-treated multiple sclerosis patients

P. Gallo, P. Perini, M. Buttarello, 1998 .

A case of Henoch-Schönlein purpura in the elderly: not just a ‘second childhood’

P. Gallo, A. Afeltra, A. Soriano, 2012, Aging Clinical and Experimental Research.

Blood-brain barrier damage restricts the reliability of quantitative formulae and isoelectric focusing in detecting intrathecally synthesized IgG

B. Tavolato, F. Bracco, P. Gallo, 1988, Journal of the Neurological Sciences.

Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients.

A. Nobili, P. Mannucci, P. Gallo, 2018, European journal of internal medicine.

Association of Multiple Sclerosis with PM 2.5 levels. Further evidence from the highly polluted area of Padua Province, Italy.

M. Cadaldini, M. Ermani, P. Gallo, 2020, Multiple sclerosis and related disorders.

Sporadic Creutzfeldt-Jakob disease presenting with isolated progressive non-fluent aphasia in a young woman

A. Cagnin, P. Gallo, G. Zanusso, 2017, Neurological Sciences.

Two-dimensional electrophoresis of cerebrospinal fluid proteins in normal and pathological conditions

B. Tavolato, L. Battistin, F. Bracco, 1985, Neurochemical Research.

Immunoglobulin light chain patterns in the cerebrospinal fluid A study with special reference to the occurrence of free light chains in cerebrospinal fluid with and without oligoclonal immunoglobulin G

B. Tavolato, P. Gallo, Å. Sidén, 1989, Journal of the Neurological Sciences.

Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.

M. Plebani, P. Gallo, M. Zaninotto, 2018, Multiple sclerosis and related disorders.

No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study

M. Calabrese, G. Palù, L. Barzon, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Cerebrovascular and neurological disorders associated with antiphospolipid antibodies in CSF and serum

B. Giometto, B. Tavolato, P. Gallo, 1994, Journal of the Neurological Sciences.

Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing–remitting multiple sclerosis

M. Calabrese, P. Gallo, M. Atzori, 2012, Multiple sclerosis.

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis

M. Trojano, L. Caniatti, O. Picconi, 2010, Multiple sclerosis.

Impairment of GH/IGF-1 Axis in the Liver of Patients with HCV-Related Chronic Hepatitis

S. Morini, G. Perrone, M. Cicala, 2017, Hormone and Metabolic Research.

Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid

K. Frei, B. Tavolato, A. Fontana, 1989, Journal of Neuroimmunology.

Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids.

C. Mussi, L. Fenoglio, M. Barbagallo, 2019, Journal of the American Medical Directors Association.

Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities

P. Gallo, M. Margoni, F. Rinaldi, 2021, Frontiers in Neurology.

The range of multiple sclerosis associated with neurofibromatosis type 1

P. Gallo, P. Perini, 2001, Journal of neurology, neurosurgery, and psychiatry.

REabsorbable vs. DUrable Polymer Drug-Eluting Stents in All-Comer PatiEnts: the REDUCE registry.

P. Gallo, M. Miglionico, M. de Michele, 2020, Coronary artery disease.

BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset

P. Gallo, F. Rinaldi, S. Ruggero, 2016, Journal of Neuroimmunology.

Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes

M. Trojano, A. Ghezzi, F. Mattioli, 2017, Multiple sclerosis.

Cortical lesion load associates with progression of disability in multiple sclerosis.

M. Calabrese, C. Romualdi, P. Gallo, 2012, Brain : a journal of neurology.

Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients

M. Filippi, C. Pozzilli, M. Rocca, 2013, Neurological Sciences.

Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study

C. Pozzilli, G. Comi, M. Trojano, 2005, Multiple sclerosis.

Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis

A Giorgio, M. Battaglini, A. Giorgio, 2010, Neurology.

Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients.

A. Nobili, P. Mannucci, P. Gallo, 2019, European journal of internal medicine.

Tumor necrosis factor alpha (TNFα) and neurological diseases Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours

B. Tavolato, P. Gallo, M. Piccinno, 1989, Journal of Neuroimmunology.

BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset

M. Ermani, P. Gallo, F. Rinaldi, 2017, Journal of Neuroinflammation.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab

Roberta Lanzillo, Antonio Uccelli, Giancarlo Comi, 2018, Neurology.

Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands

M. Plebani, P. Gallo, M. Zaninotto, 2019 .

Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey

G. Moretto, M. Calabrese, M. Ermani, 2003, Multiple sclerosis.

Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenon

P. Gallo, F. Rinaldi, P. Perini, 2017, Therapeutic advances in neurological disorders.

Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency

M. Calabrese, F. Causin, P. Gallo, 2011, Neurology.

Upper cervical cord atrophy is independent of cervical cord lesion volume in early multiple sclerosis: A two-year longitudinal study.

F. Barkhof, H. Vrenken, P. Pouwels, 2022, Multiple sclerosis and related disorders.

Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study

M. Calabrese, A. Suppiej, P. Gallo, 2009, Multiple sclerosis.

Acute disseminated encephalomyelitis in children: focus on relapsing patients.

D. De Grandis, R. Manara, A. Suppiej, 2008, Pediatric neurology.

Cortical lesions and cognitive impairment in multiple sclerosis

M. Calabrese, P. Gallo, F. Rinaldi, 2010, Neurological Sciences.

Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients

S. Bandinelli, L. Ferrucci, R. Antonelli Incalzi, 2021, Aging Clinical and Experimental Research.

Effect of IFNβ and anti-IFNβ antibodies on NK cells in multiple sclerosis patients

M. Wadhwa, A. Meager, P. Gallo, 2000, Journal of Neuroimmunology.

Transferrin receptors in rat central nervous system An immunocytochemical study

B. Giometto, B. Tavolato, P. Gallo, 1990, Journal of the Neurological Sciences.

D-KEFS ST Failure Identifies Multiple Sclerosis Patients With Worse Objective and Self-Perceived Physical and Cognitive Disability

M. Ermani, P. Gallo, F. Rinaldi, 2019, Front. Psychol..

Natalizumab strongly suppresses cortical pathology in relapsing–remitting multiple sclerosis

M. Calabrese, P. Gallo, F. Rinaldi, 2012, Multiple sclerosis.

Selective Cerebellar Atrophy Associates with Depression and Fatigue in the Early Phases of Relapse-Onset Multiple Sclerosis

P. Gallo, M. Margoni, D. Poggiali, 2020, The Cerebellum.

Sexual Dysfunction in Multiple Sclerosis: The Role of Executive Function

P. Gallo, S. Mondini, F. Rinaldi, 2023, Behavioral sciences.

Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis

M. Onofrj, M. Trojano, M. Zaffaroni, 2020, Neurological Sciences.

Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study

A. Ghezzi, F. Mattioli, C. Stampatori, 2018, Multiple sclerosis.

Designing a Self-Perception Cognitive Questionnaire for Italian Multiple Sclerosis Patients (Sclerosi Multipla Autovalutazione Cognitiva, SMAC). A Preliminary Exploratory Pilot Study

P. Gallo, M. Margoni, S. Mondini, 2021, Frontiers in Neurology.

MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis

F. Causin, P. Gallo, F. Rinaldi, 2016, Multiple sclerosis.

Therapeutic Advances in Neurological Disorders

P. Gallo, F. Rinaldi, P. Perini, 2018 .

Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic

P. Gallo, M. Margoni, 2020, Multiple sclerosis journal - experimental, translational and clinical.

The Transferrin-Tau ratio of the CSF

B. Tavolato, C. D. Zanche, P. Gallo, 1984 .

Steroid-refractory immune related hepatitis may hide viral re-activation

B. Vincenzi, G. Tonini, P. Gallo, 2020, Future science OA.

Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis

F. Causin, P. Gallo, M. Margoni, 2017, PloS one.

Potentially Inappropriate Medications, Drug–Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?

A. Nobili, P. Mannucci, R. Antonelli Incalzi, 2020, Drugs & Aging.

Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)

C. Mussi, L. Fenoglio, M. Barbagallo, 2021, Endocrine.

Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset

M. Filippi, C. Pozzilli, M. Falautano, 2022, Neurology.

Country break-out session highlights.

F. Fazekas, K. Myhr, P. Gallo, 2015, Neurodegenerative disease management.

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological Society

D. Centonze, C. Pozzilli, G. Tedeschi, 2011, Neurological Sciences.

Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

C. Mussi, L. Fenoglio, M. Barbagallo, 2021, Acta Diabetologica.

Macrophage-colony stimulating factor (M-CSF) in the cerebrospinal fluid

B. Giometto, B. Tavolato, P. Gallo, 1990, Journal of Neuroimmunology.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab II : Maternal risks

C. Pozzilli, V. Martinelli, G. Comi, 2022 .

Disease-Modifying Drugs Reduce Cortical Lesion Accumulation and Atrophy Progression in Relapsing-Remitting Multiple Sclerosis: Results from a 48-Month Extension Study

P. Gallo, M. Atzori, F. Rinaldi, 2015, Multiple sclerosis international.

M. Sormani, S. Bonavita, P. Gallo, 2023, Journal of clinical medicine.

Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study

G. Busto, P. Ambrosino, P. Gallo, 2017, World journal of gastroenterology.

A new integrated dual time-point amyloid PET/MRI data analysis method

Davide Poggiali, Osama Sabri, Solveig Tiepolt, 2017, European Journal of Nuclear Medicine and Molecular Imaging.

Quantification of normal-appearing white matter damage in early relapse-onset multiple sclerosis through neurite orientation dispersion and density imaging.

A. Bertoldo, F. Causin, P. Gallo, 2021, Multiple sclerosis and related disorders.

Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple Sclerosis

M. Sormani, P. Gallo, F. Rinaldi, 2020, Frontiers in Immunology.

Multiple Sclerosis Incidence and Prevalence Trends in the Province of Padua, Northeast Italy, 1965–2018

M. Cadaldini, P. Gallo, Marta Pengo, 2018, Neuroepidemiology.

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

D. Centonze, G. Marfia, M. Filippi, 2017, Journal of Neurology.

The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing–remitting multiple sclerosis

M. Calabrese, M. Plebani, P. Gallo, 2012, Multiple sclerosis.

Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study

Marco Rovaris, Massimo Filippi, Chiara Romualdi, 2008, NeuroImage.

Cerebrospinal fluid lymphocytes from HIV-infected patients synthesize HIV-specific antibody in vitro

B. Tavolato, L. Chieco‐Bianchi, A. Amadori, 1988, Journal of Neuroimmunology.

Immunological Findings in the CSF of HIV-1 Infected Patients

B. Tavolato, L. Chieco‐Bianchi, A. Amadori, 1990 .

Central nervous system involvement in HIV infection.

B. Tavolato, L. Chieco‐Bianchi, A. Amadori, 1988, AIDS research and human retroviruses.

Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years

M. Filippi, C. Pozzilli, V. Martinelli, 2022, Multiple sclerosis.

Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset

P. Gallo, F. Rinaldi, P. Perini, 2014, Journal of Neuroimmunology.

Search for HTLV‐I and LAV/HTLV‐III antibodies in serum and CSF of multiple sclerosis patients

B. Tavolato, L. Chieco‐Bianchi, L. Callegaro, 1986, Acta neurologica Scandinavica.

Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis

P. Gallo, M. Margoni, F. Rinaldi, 2019, Multiple sclerosis journal - experimental, translational and clinical.

Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience

C. Pozzilli, V. Martinelli, G. Comi, 2009, Neurological Sciences.

Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a: long-term results

C. Pozzilli, G. Comi, M. Trojano, 2007, Neurological Sciences.

Modeling the Distribution of New MRI Cortical Lesions in Multiple Sclerosis Longitudinal Studies

Massimiliano Calabrese, Alessio Signori, Maria Pia Sormani, 2011, PloS one.

Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis

P. Gallo, P. Perini, 2003, Journal of Neurology.

Mitoxantrone versus cyclophosphamide in secondary-progressive multiple sclerosis

M. Calabrese, L. Battistin, P. Gallo, 2006, Journal of Neurology.

Low degree of cortical pathology is associated with benign course of multiple sclerosis

M. Calabrese, C. Romualdi, P. Gallo, 2013, Multiple sclerosis.

The puzzle of multiple sclerosis: gray matter finds its place

M. Calabrese, P. Gallo, F. Rinaldi, 2011, Expert review of neurotherapeutics.

Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial

L. Provinciali, A. Ghezzi, M. Pardini, 2016, Front. Behav. Neurosci..

Immunological markers in multiple sclerosis: tackling the missing elements

P. Gallo, L. Rinaldi, 2005, Neurological Sciences.

Cortical relapses in multiple sclerosis

F. Causin, P. Gallo, F. Rinaldi, 2016, Multiple sclerosis.

Detection of IgG oligoclonal bands in unconcentrated CSF by means of agarose isoelectric focusing, double immunofixation peroxidase staining and avidin-biotin amplification

B. Tavolato, F. Bracco, P. Gallo, 1985, The Italian Journal of Neurological Sciences.

On the Intrathecal Synthesis of Immunoglobulins: Detection of BSF-2/IL-6 in CSF

K. Frei, A. Fontana, D. Leppert, 1990 .

Humoral Immunity in Multiple Sclerosis Cerebrospinal Fluid: Role of the Blood-Brain Barrier Integrity in the Detection of Intrathecally Synthesized Immunoglobulins

B. Tavolato, F. Bracco, P. Gallo, 1987 .

Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases

M. Inglese, G. Mancardi, P. Gallo, 2020, Multiple sclerosis.

Herpes simplex virus encephalitis temporally associated with dimethyl fumarate-induced lymphopenia in a multiple sclerosis patient.

P. Gallo, M. Marcon, F. Perini, 2018, Multiple sclerosis and related disorders.

Free light chains in the CSF in multiple sclerosis

B. Tavolato, L. Battistin, F. Bracco, 1987, Journal of Neurology.

Loss of Reliability and Sensitivity of Agarose Isoelectric Focusing and Quantitative Formulae in the Detection of Intrathecally Synthesized IgG in the Presence of Blood-Brain Barrier Damage

B. Tavolato, F. Bracco, P. Gallo, 1988 .

Cerebrospinal fluid examination in the differential diagnosis of inflammatory myelopathies

M. Calabrese, P. Gallo, P. Perini, 2001, Neurological Sciences.

Study of the IgG oligoclonal bands in cerebral spinal fluid in multiple sclerosis by electroimmunofixation

B. Tavolato, P. Gallo, E. Visentini, 1982, The Italian Journal of Neurological Sciences.

Immunoregulation in the Central Nervous System: Detection of Cytokines in Cerebrospinal Fluid

K. Frei, A. Fontana, D. Nadal, 1990 .

A case of multiple sclerosis with an onset mimicking the Kleine-Levin syndrome

B. Tavolato, P. Gallo, A. Opportuno, 1987, The Italian Journal of Neurological Sciences.

M. Battaglini, A. Giorgio, M. Calabrese, 2011 .

Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model.

G. Polizzi, A. Sticchi, P. Gallo, 2021, The American journal of cardiology.

Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot.

P. Gallo, Francesco Valentini, F. Piemonte, 2017, Clinical Biochemistry.

Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study

Marco Rovaris, Massimo Filippi, Massimiliano Calabrese, 2011, Multiple sclerosis.

Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4

D. Centonze, C. Pozzilli, M. Trojano, 2023, Therapeutic Advances in Neurological Disorders.

Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onset

F. Causin, S. Sartori, P. Gallo, 2020, Journal of Neurology.

Specific Smell Dysfunctions in Relapsing-Remitting Multiple Sclerosis

U. Castiello, M. Calabrese, V. Parma, 2010 .

Acute simultaneous development of brain tumour–like lesion and demyelinating polyneuropathy in a patient with chronic relapsing myelitis

P. Gallo, P. Perini, Matteo Gizzi, 2018, Multiple sclerosis.

A Randomized Study of Cardiac Resynchronization Therapy Defibrillator Versus Dual-Chamber Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy With Narrow QRS: The NARROW-CRT Study

I. Diemberger, B. Tuccillo, P. Gallo, 2013, Circulation. Arrhythmia and electrophysiology.

Increased incidence of multiple sclerosis in the Veneto region, Italy

M. Calabrese, P. Gallo, F. Rinaldi, 2013, Multiple sclerosis.

Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register

C. Mussi, L. Fenoglio, M. Barbagallo, 2019, Internal and Emergency Medicine.

Improved detection of free light chains in unconcentrated CSF by agarose IEF and avidin-biotin-peroxidase staining.

B. Tavolato, L. Battistin, F. Bracco, 1986 .

Brain tumors: detection of B-cell stimulatory factor-2/interleukin-6 in the absence of oligoclonal bands of immonoglobulins

K. Frei, M. Yașargil, A. Fontana, 1989, Journal of Neuroimmunology.

Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: a preliminary report

M. Calabrese, P. Gallo, F. Rinaldi, 2010, Neurological Sciences.

P. Gallo, E. Pilotto, F. Rinaldi, 2023, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Abnormal Papillary Muscle Signal on Cine MRI As a Typical Feature of Mitral Valve Prolapse

P. Gallo, A. Cappelletti, S. Dellegrottaglie, 2020, Scientific Reports.

BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset

M. Ermani, P. Gallo, F. Rinaldi, 2017, Journal of Neuroinflammation.

Monoclonal and Oligoclonal Immunoglobulin M in the Cerebrospinal Fluid

B. Tavolato, F. Bracco, P. Gallo, 1987 .

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

F. Barkhof, X. Montalban, L. Kappos, 2010, The New England journal of medicine.

Therapeutic Advances in Neurological Disorders

P. Gallo, F. Rinaldi, P. Perini, 2018 .

The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention

P. Gallo, A. Picardi, U. Vespasiani‐Gentilucci, 2016, Archives of medical science : AMS.

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

M. Filippi, F. Agosta, M. Calabrese, 2009, Archives of neurology.

Protection from experimental autoimmune encephalomyelitis (EAE): non-depleting anti-CD4 mAb treatment induces peripheral T-cell tolerance to MBP in PL/J mice

B. Tavolato, P. Gallo, A. Facchinetti, 1997, Journal of Neuroimmunology.

The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients

S. Morini, P. Gallo, A. Porcari, 2016, Scandinavian journal of gastroenterology.

Cortical pathology and cognitive impairment in multiple sclerosis

M. Calabrese, P. Gallo, F. Rinaldi, 2011, Expert review of neurotherapeutics.

Association of Multiple Sclerosis with PM 2.5 levels. Further evidence from the highly polluted area of Padua Province, Italy.

M. Cadaldini, M. Ermani, P. Gallo, 2020, Multiple sclerosis and related disorders.

Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification

L. Grimaldi, G. Palù, F. Bandini, 2012, Journal of Neuroimmune Pharmacology.

A 3‐year magnetic resonance imaging study of cortical lesions in relapse‐onset multiple sclerosis

M. Filippi, M. Rocca, M. Calabrese, 2009, Annals of neurology.

Access to magnetic resonance imaging of patients with magnetic resonance-conditional pacemaker and implantable cardioverter-defibrillator systems: results from the Really ProMRI study

G. Licciardello, L. Padeletti, A. Vado, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.